Inactive Instrument

News CuraGen Corporation

Stocks

US23126R1014

Pharmaceuticals

End-of-day quote
- USD - Intraday chart for CuraGen Corporation
09-07-31 CURAGEN CO USD0.01 : CuraGen Reports Second Quarter 2009 Financial Results PR
-1-11-29 CURAGEN : Reports Third Quarter 2008 Financial Results PR
-1-11-29 CURAGEN : to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 PR
-1-11-29 CURAGEN : Corporation Receives Notification from NASDAQ PR
-1-11-29 CURAGEN : Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE PR
-1-11-29 CURAGEN : to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference PR
-1-11-29 CURAGEN : Corporation Regains NASDAQ Listing Compliance PR
-1-11-29 Curagen : CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million PR
-1-11-29 Curagen : CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million PR
-1-11-29 Curagen : CuraGen Reports First Quarter 2008 Financial Results PR
-1-11-29 Curagen : CuraGen Sells Ownership of Belinostat to TopoTarget A/S PR
-1-11-29 Curagen : CuraGen to Present at the BIO CEO & Investor Conference PR
-1-11-29 Curagen : CuraGen Reports Fourth Quarter and Year End 2007 Financial Results PR
-1-11-29 CURAGEN : Announces Board of Director Changes PR
-1-11-29 CURAGEN : CuraGen's Board of Directors to Evaluate Strategic Initiatives PR
-1-11-29 CURAGEN : Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 PR
-1-11-29 CURAGEN : to Present at the Rodman & Renshaw Annual Global Investment Conference PR
No results match your criteria
  1. Stock Market
  2. Stocks
  3. Stock
  4. News CuraGen Corporation